Activating mutations of the oncogene EZH2 in cutaneous melanoma revealed by next generation sequencing
Enhancer of zeste homolog 2 (EZH2) is a histone methyltransferase that promotes tumorigenesis by epigenetic repression of tumor suppressor genes. Although EZH2 is overexpressed in many malignancies, activating EZH2 mutations have been described predominantly in follicular lymphoma and diffuse large...
Saved in:
Main Authors: | Paul W. Harms (Author), Alexandra C. Hristov (Author), David S. Kim (Author), Tobenna Anens (Author), Michael J. Quist (Author), Javed Siddiqui (Author), Shannon Carskadon (Author), Rohit Mehra (Author), Douglas R. Fullen (Author), Timothy M. Johnson (Author), Arul M. Chinnaiyan (Author), Nallasivam Palanisamy (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2014-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
: A Novel ROS1 Oncogenic Fusion Detected on Next Generation Sequencing
by: Anurag Mehta, et al.
Published: (2024) -
Long Intergenic Noncoding RNA 00511 Acts as an Oncogene in Non-small-cell Lung Cancer by Binding to EZH2 and Suppressing p57
by: Cheng-Cao Sun, et al.
Published: (2016) -
Quality assessment of a clinical next-generation sequencing melanoma panel within the Italian Melanoma Intergroup (IMI)
by: Irene Vanni, et al.
Published: (2020) -
Identification of novel targetable mutations in metastatic anorectal melanoma by next-generation sequencing
by: Emily D. Cai, BA, et al.
Published: (2017) -
Oncogenes and Carcinogenesis
Published: (2019)